Bettelli Lab

Introduction

The main focus of the Bettelli Lab is to identify the cell types of the immune system and mechanisms, which induce and regulate the development of autoimmunity.

Walk MS Group Photo 2019
Dr. Bettelli and other BRI supporters at the 2019 Walk MS Event.
Estelle Bettelli
Member

Estelle Bettelli, PhD

Member, Fundamental Immunology Program; Principal Investigator, Bettelli Lab; Affiliated Professor, UW Department of Immunology
View Full Bio

Lab Members

Pushpalatha Palle

Pushpa Palle, PhD

Post Doctoral Research Associate, Bettelli Lab
Yev Yuzefpolskiy

Yevgeniy Yuzefpolskiy, PhD

Post Doctoral Research Associate, Bettelli Lab

Related Stories

Featured Tumor Microenvironment Cancer T-Cell
June 30, 2023

What Do T Cells Like to Eat? The Answer Could Stop Multiple Sclerosis

Cells, like people, get their energy from sugars, proteins and fats. Many cells have highly specialized diets — think of some loving kale while others prefer Texas BBQ.
Read Article
Blog Main Image - 3D Abstract Neurological Blue
June 17, 2022

Do MS Treatments Make Vaccines Less Effective?

This issue of vaccine efficacy has taken center stage in light of the pandemic. A BRI team led by Estelle Bettelli, PhD, and Yevgeniy Yuzefpolskiy, PhD, recently made key findings about how three different medicines for multiple sclerosis (MS) impact response to COVID-19 vaccines.

Read Article
Blog Main Image - Researcher Woman Using Microscope Lab
September 11, 2020

Taking on Multiple Sclerosis

Dr. Bettelli’s team develops sophisticated MS models to investigate its mysteries and pursue innovative therapies. We recently asked her for an update on BRI’s MS progress.

Read Article

News

Blog Main Image - BRI Researcher Handling Samples Hood

Benaroya Research Institute Awarded $11.4 M NIH U19 Grant to Profile Respiratory Viral Infections in Vulnerable Populations and $3.9M NIH R01 Grant to Develop New Treatments for Type 1 Diabetes

Read More
Blog Main Image - 3D COVID Syringes

Benaroya Research Institute Team Examines COVID Vaccine Response in People Under Treatment for MS and Other Autoimmune Diseases

Read More
News Healthline

Healthline reports about the new MS genetics grant

Read More